No PfATPase6 S769N mutation found in Plasmodium falciparum isolates from China

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Zhang, Guoqing ^a   Guan, Yayi ^a   Zheng, Bin ^a   Wu, Song ^a   Tang, Linhua ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; SERINE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; ATP6 PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL DNA;

ARTICLE; CHINA; GENE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; NONHUMAN; PARASITE ISOLATION; PFATPASE6 GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; ANIMAL; CHEMISTRY; CODON; DNA SEQUENCE; DRUG EFFECT; DRUG RESISTANCE; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; MUTATION; PARASITOLOGY;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CALCIUM-TRANSPORTING ATPASES; CHINA; CODON; DNA, PROTOZOAN; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MUTATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 47349124330     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-122     Document Type: Article

References (19)

1. Progress in malaria control in China. LH Tang, Chinese medical journal 2000 113 1 89 92 11775219
2. [Malaria situation in the People' s Republic of China in 2006]. SS Zhou Y Wang LH Tang, Chinese journal of parasitology & parasitic diseases 2007 25 6 439 411
3. Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria. GQ Li K Arnold XB Guo HX Jian LC Fu, Lancet 1984 2 8416 1360 1361 10.1016/S0140-6736(84)92057-9 6150365
4. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. GQ Li XB Guo LC Fu HX Jian XH Wang, Transactions of the Royal Society of Tropical Medicine and Hygiene 1994 88 Suppl 1 S5 6 10.1016/0035-9203(94)90460-X
5. WHO ultimatum on artemisinin monotherapy is showing results. C Rehwagen, BMJ (Clinical research ed 2006 332 7551 1176 16709988 10.1136/bmj.332.7551.1176- b
6. Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China. H Yang D Liu Y Yang B Fan P Yang X Li C Li Y Dong C Yang, Transactions of the Royal Society of Tropical Medicine and Hygiene 2003 97 2 226 228 10.1016/S0035-9203(03)90127-1
7. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. A Afonso P Hunt S Cheesman AC Alves CV Cunha V do Rosario P Cravo, Antimicrobial agents and chemotherapy 2006 50 2 480 489 10.1128/AAC.50.2.480-489.2006
8. Artemisinins target the SERCA of Plasmodium falciparum. U Eckstein-Ludwig RJ Webb ID Van Goethem JM East AG Lee M Kimura PM O'Neill PG Bray SA Ward S Krishna, Nature 2003 424 6951 957 961 10.1038/nature01813 12931192
9. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. AC Uhlemann A Cameron U Eckstein-Ludwig J Fischbarg P Iserovich FA Zuniga M East A Lee L Brady RK Haynes S Krishna, Nature structural & molecular biology 2005 12 7 628 629 10.1038/nsmb947 15937493
10. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. R Jambou E Legrand M Niang N Khim P Lim B Volney MT Ekala C Bouchier P Esterre T Fandeur O Mercereau-Puijalon, Lancet 2005 366 9501 1960 1963 10.1016/S0140-6736(05)67787-2 16325698
11. PCR and strain identification in Plasmodium falciparum. J Wooden S Kyes CH Sibley, Parasitology today (Personal ed 1993 9 8 303 305 10.1016/0169- 4758(93)90131-X 15463789
12. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. RJ Pearce C Drakeley D Chandramohan F Mosha C Roper, Antimicrobial agents and chemotherapy 2003 47 4 1347 1354 10.1128/AAC.47.4.1347-1354.2003
13. [In-vitro sensitivity of Plasmodium falciparum to the components of dihydroartemisinin compounds in dongfang city of hainan province]. L Liu P Chen F Ou C Fu, Journal of Guangzhou University of Traditional Chinese Medicine 2005 22 5 377 379
14. [In vitro sensitivity of Plasmodium falciparum to derivatives of artemisinin, pyronaridine and chloroquine in Yunnan]. H Yang D Liu K Huang Y Dong Y Yang P Yang M Liao C Zhang R Liu, Chinese Journal of Parasitology and Parasitic Diseases 1997 15 5 292 296
15. [Randomized trial of Artekin and Artekin(T) for treatment of uncomplicated falciparum malaria patients]. Y Xu FZ Ou PQ Chen JP Song LC Fu, China Tropical Medicine 2003 3 6 723 725
16. [Clinical study on the efficacy of dihydroartemisinin and piperaquine in treatment of multi-drug resistant Plasmodium falciparum]. XD Sun ZX Zhang DQ Liu GZ Huang Y Deng CL Zhang SL Wang HB Li M Huang YC Jiang LF Zhao YH Xiao, China tropical medicine 2006 6 2 211 212
17. Artemisinin resistance: how can we find it? H Noedl, Trends in parasitology 2005 21 9 404 405 10.1016/j.pt.2005.06.012 16046187
18. Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania. K Mugittu B Genton H Mshinda HP Beck, Malaria journal 2006 5 126 17177997 10.1186/1475-2875-5-126
19. Plasmodium falciparum from Para state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6. ID Ferreira A Martinelli LA Rodrigues EL do Carmo VE do Rosario MM Povoa P Cravo, Trop Med Int Health 2008 13 2 199 207 18304266